Purpose . This study aims to evaluate the performance of a commercial 1.5 T MR-Linac by analyzing its patient-specific quality assurance (QA) data collected during one full year of clinical operation. Methods and Materials . The patient-specific QA system consisted of offline delivery QA (DQA) and online calculation-based QA. Offline DQA was based on ArcCHECK-MR combined with an ionization chamber. Online QA was performed using RadCalc that calculated and compared the point dose calculation with the treatment planning system (TPS). A total of 24 patients with 189 treatment fractions were enrolled in this study. Gamma analysis was performed and the threshold that encompassed 95% of QA results (T95) was reported. The plan complexity metric was calculated for each plan and compared with the dose measurements to determine whether any correlation existed. Results . All point dose measurements were within 5% deviation. The mean gamma passing rates of the group data were found to be 96.8 ± 4.0% and 99.6 ± 0.7% with criteria of 2%/2mm and 3%/3mm, respectively. T95 of 87.4% and 98.2% was reported for the overall group with the two passing criteria, respectively. No statistically significant difference was found between adaptive treatments with adapt-to-position (ATP) and adapt-to-shape (ATS), whilst the category of pelvis data showed a better passing rate than other sites. Online QA gave a mean deviation of 0.2 ± 2.2%. The plan complexity metric was positively correlated with the mean dose difference whilst the complexity of the ATS cohort had larger variations than the ATP cohort. Conclusions . A patient-specific QA system based on ArcCHECK-MR, solid phantom and ionization chamber has been well established and implemented for validation of treatment delivery of a 1.5 T MR-Linac. Our QA data obtained over one year confirms that good agreement between TPS calculation and treatment delivery was achieved.
The incidence of miscarriage in early pregnancy, between 5–20 weeks, is common, with a prevalence of between 5–22% of all pregnancies. Miscarriage can have physical, social, and mental health impacts on women and their families. In societies such as Taiwan, where the birth rate is falling and life expectancy is increasing, there is concern that factors that reduce birth rates will have detrimental economic and societal effects. Progesterone has a significant role in maintaining early and successful pregnancy to term. Evidence from preclinical and clinical research on the roles of progesterone has supported recent clinical guidelines in obstetrics and gynecology to reduce rates of early miscarriage and improve methods of assisted reproductive technology (ART). This article aims to present an evidence-based review of current recommendations for the use of progesterone in early pregnancy to reduce miscarriage rates and in luteal phase support for ART, including embryo transfer.
This paper proposed a low cost worm-shape robot that can mimic the locomotion of a caterpillar to crawl by arching and stretching its body. Based on the process of implementing the caterpillar robot, the participated students can built up their interdisciplinary skills. Students have to integrate the technologies of micro-controllers, sensors, materials and mechanisms. We used a Motoduino U1 module to drive 4 servomotors and Bluetooth module to communicate between robot and users. In order to imitate gaits of caterpillars, the body of the robot was made by using discrete PVC rings to flexibly arch. The robot also can be remotely controlled to crawl forward/back or right/left, and change its height of arched back. The weight and total length of the robot were bout 470g and 65cm, respectively. The experiment shows that when the caterpillar robot moves in line, the averaged speed of robot can be 25m/hr. The maximum rotating angle is 30° and the minimum rotating diameter is 120cm.
Kilovoltage intrafraction monitoring (KIM) is a novel real-time IGRT system; KIM uses the gantry-mounted kilovoltage imaging system during the therapy delivery to measure the positions of radio-opaque markers in each image, and then compute and display, in real-time, the 3D position of the center of the markers relative to the treatment isocenter. The positions are then used to determine the guidance decision: continue the treatment or gate the treatment and shift the patient. The first prospective clinical trial of KIM was performed with prostate cancer patients being treated with VMAT. We reported the accuracy and precision measurements from this trial.